Mathew Blackman
Stock Analyst at Stifel
(3.82)
# 669
Out of 4,876 analysts
61
Total ratings
51.16%
Success rate
10.12%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mathew Blackman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INGN Inogen | Maintains: Hold | $10 → $7 | $7.23 | -3.18% | 13 | May 8, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $60 → $31 | $19.11 | +62.22% | 6 | May 1, 2025 | |
| PEN Penumbra | Maintains: Buy | $301 → $318 | $253.58 | +25.40% | 2 | Apr 24, 2025 | |
| CLPT ClearPoint Neuro | Maintains: Buy | $19 → $25 | $12.02 | +107.99% | 3 | Apr 1, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $25 | $14.99 | +66.78% | 1 | Feb 24, 2025 | |
| PODD Insulet | Maintains: Hold | $245 → $293 | $309.83 | -5.43% | 5 | Feb 21, 2025 | |
| GMED Globus Medical | Maintains: Buy | $92 → $94 | $58.82 | +59.81% | 5 | Feb 21, 2025 | |
| OFIX Orthofix Medical | Upgrades: Buy | $18 → $24 | $11.04 | +117.39% | 5 | Nov 8, 2024 | |
| CERS Cerus | Maintains: Buy | $6 → $3 | $1.36 | +120.59% | 1 | Oct 17, 2024 | |
| DXCM DexCom | Maintains: Buy | $90 → $100 | $85.04 | +17.59% | 11 | Aug 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $16 | $10.90 | +46.79% | 5 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $18 → $11 | $9.42 | +16.77% | 4 | May 10, 2023 |
Inogen
May 8, 2025
Maintains: Hold
Price Target: $10 → $7
Current: $7.23
Upside: -3.18%
Tandem Diabetes Care
May 1, 2025
Maintains: Buy
Price Target: $60 → $31
Current: $19.11
Upside: +62.22%
Penumbra
Apr 24, 2025
Maintains: Buy
Price Target: $301 → $318
Current: $253.58
Upside: +25.40%
ClearPoint Neuro
Apr 1, 2025
Maintains: Buy
Price Target: $19 → $25
Current: $12.02
Upside: +107.99%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $25
Current: $14.99
Upside: +66.78%
Insulet
Feb 21, 2025
Maintains: Hold
Price Target: $245 → $293
Current: $309.83
Upside: -5.43%
Globus Medical
Feb 21, 2025
Maintains: Buy
Price Target: $92 → $94
Current: $58.82
Upside: +59.81%
Orthofix Medical
Nov 8, 2024
Upgrades: Buy
Price Target: $18 → $24
Current: $11.04
Upside: +117.39%
Cerus
Oct 17, 2024
Maintains: Buy
Price Target: $6 → $3
Current: $1.36
Upside: +120.59%
DexCom
Aug 23, 2024
Maintains: Buy
Price Target: $90 → $100
Current: $85.04
Upside: +17.59%
Aug 1, 2024
Maintains: Buy
Price Target: $19 → $16
Current: $10.90
Upside: +46.79%
May 10, 2023
Downgrades: Hold
Price Target: $18 → $11
Current: $9.42
Upside: +16.77%